1-5 of 5
Andreas Günther
Close
Sort by
Journal Articles

Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma: The Phase I/II EMN09 Study

Martin Gramatzki, Andreas Günther, Massimo Offidani, MD, Monika Engelhardt, Paolo Corradini, Silvia Gentili, Vittorio Montefusco, Francesca Patriarca, MD, Natalie Schub, Hermann Einsele, MD, Pieter Sonneveld, Antonio Palumbo, MD, Francesca Gay
Journal: Blood
Blood (2016) 128 (22): 3334.
https://doi.org/10.1182/blood.V128.22.3334.3334
Published: 2016
Journal Articles

Phase 1 Study Update of the Novel Pan-Pim Kinase Inhibitor LGH447 in Patients with Relapsed/ Refractory Multiple Myeloma

Marc S Raab, MD PhD, Enrique M Ocio, Sheeba K. Thomas, MD, Andreas Günther, MD, Yeow-Tee Goh, MBBS,MMed, Daniel Lebovic, MD, Andrzej Jakubowiak, MD PhD, Dongweon Song, F Xiang, Apurva Patel, K. Gary Vanasse, MD, Shaji Kumar, MD
Journal: Blood
Blood (2014) 124 (21): 301.
https://doi.org/10.1182/blood.V124.21.301.301
Published: 2014
Journal Articles

Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant

Stefan Knop, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Albrecht Reichle, Wolf Rösler, MD, Florian Bassermann, MD, Bernd Hertenstein, MD, Isrid Sturm, MD, Christoph Röllig, MD, Helmut Ostermann, MD, Kerstin Schäfer-Eckart, MD, Mark Ringhoffer, MD, Andreas Günther, Christian Junghanss, MD, Harald Biersack, MD, Susanne Strifler, MD, Andreas Bachinger, Hermann Einsele, MD, Ralf C. Bargou
Journal: Blood
Blood (2014) 124 (21): 177.
https://doi.org/10.1182/blood.V124.21.177.177
Published: 2014
Journal Articles

Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies with CD20-Specific Immunoligands Engaging NKG2D or NKp30

Matthias Peipp, PhD, Christian Kellner, PhD, Andreas Günther, MD, Andreas Humpe, MD, Roland Repp, MD, Katja Klausz, PhD, Stefanie Derer, PhD, Thomas Valerius, MD, Jan G.J. van de Winkel, PhD, Paul W.H.I. Parren, PhD, Martin Gramatzki, MD
Journal: Blood
Blood (2014) 124 (21): 1779.
https://doi.org/10.1182/blood.V124.21.1779.1779
Published: 2014
Journal Articles

Phase 1 Study Of The Novel Pan-Pim Kinase Inhibitor LGH447 In Patients With Relapsed/ Refractory Multiple Myeloma

Marc S Raab, MD, Enrique M. Ocio, Sheeba K. Thomas, M.D., Andreas Günther, Daniel Lebovic, MD, Shaji K Kumar, MD, Andrzej J. Jakubowiak, MD, PhD, Dongweon Song, Fang Xiang, David Hynds, K. Gary Vanasse, M.D., Yeow Tee Goh, MD
Journal: Blood
Blood (2013) 122 (21): 3186.
https://doi.org/10.1182/blood.V122.21.3186.3186
Published: 2013